AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR WOMEN WITH BREAST-CANCER - VERY SAFE CLINICAL PROCEDURE, BUT LACK OF DATA FROM LARGE RANDOMIZED TRIALS AND LACK OF CLINICAL-PRACTICE GUIDELINES
Authors: HINTERBERGER W RUCKSER R KIER P HABERTHEUER KH KITTL E HINTERBERGERFISCHER M SELLENY S HAUSER A SASSE D ZELENKA P SEBESTA C SCHMID A BAUER K
Citation: W. Hinterberger et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR WOMEN WITH BREAST-CANCER - VERY SAFE CLINICAL PROCEDURE, BUT LACK OF DATA FROM LARGE RANDOMIZED TRIALS AND LACK OF CLINICAL-PRACTICE GUIDELINES, Bone marrow transplantation, 22, 1998, pp. 22-22
PROLACTIN, A CO-CYTOKINE OF INTERLEUKIN-2, AFTER AUTOLOGOUS AND ALLOGENEIC STEM-CELL TRANSPLANTATION (TX) IN MAN - IMPLICATIONS FOR POST-TXCONSOLIDATIVE IMMUNOTHERAPY AND IMMUNE-MODULATION
Authors: HINTERBERGERFISCHER M OGRIS E KIER P BAUER K KITTL E LECHNER K HABERTHEUER KH RUCKSER R SCHMID A SELLENY S SEBASTA C ZELENKA P HINTERBERGER W
Citation: M. Hinterbergerfischer et al., PROLACTIN, A CO-CYTOKINE OF INTERLEUKIN-2, AFTER AUTOLOGOUS AND ALLOGENEIC STEM-CELL TRANSPLANTATION (TX) IN MAN - IMPLICATIONS FOR POST-TXCONSOLIDATIVE IMMUNOTHERAPY AND IMMUNE-MODULATION, Bone marrow transplantation, 22, 1998, pp. 27-27
LEUKEMIA-FREE SURVIVAL AND MORTALITY IN PATIENTS WITH REFRACTORY OR RELAPSED ACUTE-LEUKEMIA GIVEN MARROW TRANSPLANTS FROM SIBLING AND UNRELATED DONORS
Authors: GREINIX HT REITER E KEIL F FISCHER G LECHNER K DIECKMANN K LEITNER G SCHULENBURG A HOECKER P HAAS OA KNOEBL P MANNHALTER C FONATSCH C HINTERBERGER W KALHS P
Citation: Ht. Greinix et al., LEUKEMIA-FREE SURVIVAL AND MORTALITY IN PATIENTS WITH REFRACTORY OR RELAPSED ACUTE-LEUKEMIA GIVEN MARROW TRANSPLANTS FROM SIBLING AND UNRELATED DONORS, Bone marrow transplantation, 21(7), 1998, pp. 673-678
AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (APBSCT) IN BREAST-CANCER - RESULTS OF THE DONAUSPITAL, VIENNA
Authors: RUCKSER R KIER P HABERTHEUER KH KITTL E HAUSER A SELLENY S REINER G RENNER K ZELENKA P SASSE D PARTH E HONIGER S SEBESTA C SCHMID A LANZENBERGER F HARTMANN G SCHIESSEL R BAUER K HINTERBERGER W
Citation: R. Ruckser et al., AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (APBSCT) IN BREAST-CANCER - RESULTS OF THE DONAUSPITAL, VIENNA, Bone marrow transplantation, 21, 1998, pp. 209-209
DIAGNOSTIC CHALLENGES OF HEPATITIS-C VIRUS-INFECTIONS
Authors: HUBER K SEBESTA C WOROFKA B KITTL E HOFMANN J KLAR S HINTERBERGER W BAUER K
Citation: K. Huber et al., DIAGNOSTIC CHALLENGES OF HEPATITIS-C VIRUS-INFECTIONS, Medicamentos de actualidad, 34(1), 1998, pp. 11-15
SIGNIFICANT ELEVATION OF TUMOR-ASSOCIATED ISOFORMS OF SOLUBLE CD44 INSERUM OF NORMAL INDIVIDUALS CAUSED BY CIGARETTE-SMOKING
Authors: KITTL EM RUCKSER R RECHWEICHSELBRAUN I HINTERBERGER W BAUER K
Citation: Em. Kittl et al., SIGNIFICANT ELEVATION OF TUMOR-ASSOCIATED ISOFORMS OF SOLUBLE CD44 INSERUM OF NORMAL INDIVIDUALS CAUSED BY CIGARETTE-SMOKING, European journal of clinical chemistry and clinical biochemistry, 35(2), 1997, pp. 81-84
DOSE-RESPONSE RELATIONSHIP OF COMPLEMENTARY RADIOTHERAPY FOLLOWING 4 CYCLES OF COMBINATION CHEMOTHERAPY IN INTERMEDIATE-STAGE HODGKINS-DISEASE
Authors: LOEFFLER M DIEHL V PFREUNDSCHUH M RUHL U HASENCLEVER D NISTERSBACKES H SIEBER M TESCH H FRANKLIN J GEILEN W BARTELS H CARTONI C DOLKEN G ENZIAN J FUCHS R GASSMANN W GERHARTZ H HAGENAUKAMP U HILLER E HINKELBEIN H HINTERBERGER W KIRCHNER H KOCH P KRUGER B KURTEN H KUTZNER K LOOS U MENDE W MULLER H OERTEL W PETSCH S PFAB R PFLUGER H ROHLOFF R SAUER R SCHALK K SCHICK HD SCHOPPE W SZEPESI S TEICHMANN J WORST P FISCHER R GEORGII A HUBNER K SCHWARZE EW
Citation: M. Loeffler et al., DOSE-RESPONSE RELATIONSHIP OF COMPLEMENTARY RADIOTHERAPY FOLLOWING 4 CYCLES OF COMBINATION CHEMOTHERAPY IN INTERMEDIATE-STAGE HODGKINS-DISEASE, Journal of clinical oncology, 15(6), 1997, pp. 2275-2287
EXCELLENT LONG-TERM SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION IN PATIENTS WITH SEVERE APLASTIC-ANEMIA
Authors: REITER E KEIL F BRUGGER S KALHS P RABITSCH W HINTERBERGER W FISCHER G ROSENMAYR A HAAS O VOLC B LECHNER K GREINIX HT
Citation: E. Reiter et al., EXCELLENT LONG-TERM SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION IN PATIENTS WITH SEVERE APLASTIC-ANEMIA, Bone marrow transplantation, 19(12), 1997, pp. 1191-1196
EVALUATION OF SOLUBLE CD44 SPLICE VARIANT V5 IN THE DIAGNOSIS AND FOLLOW-UP IN BREAST-CANCER PATIENTS
Authors: KITTL EM RUCKSER R SELLENY S SAMEK V HOFMANN J HUBER K REINER A OGRIS E HINTERBERGER W BAUER K
Citation: Em. Kittl et al., EVALUATION OF SOLUBLE CD44 SPLICE VARIANT V5 IN THE DIAGNOSIS AND FOLLOW-UP IN BREAST-CANCER PATIENTS, Experimental and clinical immunogenetics, 14(4), 1997, pp. 264-272
SERUM LEVELS OF SOLUBLE CD44 VARIANT ISOFORMS ARE ELEVATED IN RHEUMATOID-ARTHRITIS
Authors: KITTL EM HABERHAUER G RUCKSER R SELLENY S RECHWEICHSELBRAUN I HINTERBERGER W BAUER K
Citation: Em. Kittl et al., SERUM LEVELS OF SOLUBLE CD44 VARIANT ISOFORMS ARE ELEVATED IN RHEUMATOID-ARTHRITIS, Rheumatology international, 16(5), 1997, pp. 181-186
GRANULOCYTE-COLONY-STIMULATING FACTOR AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY FOR ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A RANDOMIZED PHASE-III STUDY
Authors: GEISSLER K KOLLER E HUBMANN E NIEDERWIESER D HINTERBERGER W GEISSLER D KYRLE P KNOBL P PABINGER I THALHAMMER R SCHWARZINGER I MANNHALTER C JAEGER U HEINZ R LINKESCH W LECHNER K
Citation: K. Geissler et al., GRANULOCYTE-COLONY-STIMULATING FACTOR AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY FOR ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A RANDOMIZED PHASE-III STUDY, Blood, 90(2), 1997, pp. 590-596
BONE-MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA - HAS OUTCOME IMPROVED
Authors: PASSWEG JR SOCIE G HINTERBERGER W BACIGALUPO A BIGGS JC CAMITTA BM CHAMPLIN RE GALE RP GLUCKMAN E GORDONSMITH EC HOWS JM KLEIN JP NUGENT ML PASQUINI R ROWLINGS PA SPECK B TICHELLI A ZHANG MJ HOROWITZ MM BORTIN MM
Citation: Jr. Passweg et al., BONE-MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA - HAS OUTCOME IMPROVED, Blood, 90(2), 1997, pp. 858-864
RESULTS OF TRANSPLANTING BONE-MARROW FROM GENETICALLY IDENTICAL-TWINSINTO PATIENTS WITH APLASTIC-ANEMIA
Authors: HINTERBERGER W ROWLINGS PA HINTERBERGERFISCHER M GIBSON J JACOBSEN N KLEIN JP KOLB HJ STEVENS DA HOROWITZ MM GALE RP
Citation: W. Hinterberger et al., RESULTS OF TRANSPLANTING BONE-MARROW FROM GENETICALLY IDENTICAL-TWINSINTO PATIENTS WITH APLASTIC-ANEMIA, Annals of internal medicine, 126(2), 1997, pp. 116
LONG-TERM LEUKEMIA-FREE SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
Authors: GREINIX HT KEIL F BRUGGER SA REITER E LINKESCH W LECHNER K SCHNEIDER B DIECKMANN KU FISCHER G SCHWARZINGER I HAAS O HINTERBERGER W MANNHALTER C GEISSLER K HOCKER P JAGER U KALHS P
Citation: Ht. Greinix et al., LONG-TERM LEUKEMIA-FREE SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA, Annals of hematology, 72(2), 1996, pp. 53-59
CHEMOTHERAPY VERSUS TRANSPLANTS FOR ACUTE MYELOGENOUS LEUKEMIA IN 2NDREMISSION
Authors: GALE RP HOROWITZ MM REES JKH GRAY RG OKEN MM ESTEY EH KIM KM ZHANG MJ ASH RC ATKINSON K CHAMPLIN RE DICKE KA GAJEWSKI JL GOLDMAN JM HELBIG W HENSLEEDOWNEY PJ HINTERBERGER W JACOBSEN N KEATING A KLEIN JP MARMONT AM PRENTICE HG REIFFERS J RIMM AA ROWLINGS PA SOBOCINSKI KA SPECK B WINGARD JR BORTIN MM
Citation: Rp. Gale et al., CHEMOTHERAPY VERSUS TRANSPLANTS FOR ACUTE MYELOGENOUS LEUKEMIA IN 2NDREMISSION, Leukemia, 10(1), 1996, pp. 13-19
RISK-FACTORS FOR HEPATIC VENOOCCLUSIVE DISEASE FOLLOWING HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTS FOR LEUKEMIA
Authors: ROZMAN C CARRERAS E QIAN C GALE RP BORTIN MM ROWLINGS PA ASH RC CHAMPLIN RE HENSLEEDOWNEY PJ HERZIG RH HINTERBERGER W KLEIN JP PRENTICE HG REIFFERS J ZWAAN FE HOROWITZ MM
Citation: C. Rozman et al., RISK-FACTORS FOR HEPATIC VENOOCCLUSIVE DISEASE FOLLOWING HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTS FOR LEUKEMIA, Bone marrow transplantation, 17(1), 1996, pp. 75-80
ERCP AND BALLOON DILATION IS A VALUABLE ALTERNATIVE TO SURGICAL BILIODIGESTIVE ANASTOMOSIS IN THE LONG COMMON CHANNEL SYNDROME IN CHILDHOOD- REPLY
Authors: SEBESTA C ROKITANSKY A ROSEN H SCHMID A KIER P RUCKSER R HINTERBERGER W
Citation: C. Sebesta et al., ERCP AND BALLOON DILATION IS A VALUABLE ALTERNATIVE TO SURGICAL BILIODIGESTIVE ANASTOMOSIS IN THE LONG COMMON CHANNEL SYNDROME IN CHILDHOOD- REPLY, Endoscopy, 28(8), 1996, pp. 724-725
BONE-MARROW TRANSPLANTS FROM GENETICALLY-IDENTICAL TWINS IN PERSONS WITH APLASTIC-ANEMIA
Authors: GALE RP HOROWITZ MM HINTERBERGER W HINTERBERGERFISCHER M ROWLINGS PA
Citation: Rp. Gale et al., BONE-MARROW TRANSPLANTS FROM GENETICALLY-IDENTICAL TWINS IN PERSONS WITH APLASTIC-ANEMIA, Experimental hematology, 23(8), 1995, pp. 860-860
ERCP AND BALLOON DILATION IS A VALUABLE ALTERNATIVE TO SURGICAL BILIODIGESTIVE ANASTOMOSIS IN THE LONG COMMON CHANNEL SYNDROME IN CHILDHOOD
Authors: SEBESTA C SCHMID A KIER P RUCKSER R TIEFENGRABER E ROSEN H STELZHAMMER K GEISSLER K HRUBY W HORCHER EP HINTERBERGER W
Citation: C. Sebesta et al., ERCP AND BALLOON DILATION IS A VALUABLE ALTERNATIVE TO SURGICAL BILIODIGESTIVE ANASTOMOSIS IN THE LONG COMMON CHANNEL SYNDROME IN CHILDHOOD, Endoscopy, 27(9), 1995, pp. 709-710
ALLOGENEIC MARROW TRANSPLANTATION BEYOND THE AGE OF 40 YEARS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCY
Authors: KALHS P BRUGGER S KEIL F HOCKER P HAWLICZEK R HINTERBERGER W LECHNER K LINKESCH W GREINIX HT
Citation: P. Kalhs et al., ALLOGENEIC MARROW TRANSPLANTATION BEYOND THE AGE OF 40 YEARS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCY, Blood, 86(10), 1995, pp. 3791-3791
SYSTEMIC LUPUS-ERYTHEMATOSUS FOLLOWING THYMECTOMY
Authors: FRIES W HABERHAUER G HINTERBERGER W
Citation: W. Fries et al., SYSTEMIC LUPUS-ERYTHEMATOSUS FOLLOWING THYMECTOMY, Aktuelle Rheumatologie, 19(6), 1994, pp. 201-204
UNTITLED - FOREWORD
Authors: HINTERBERGER W
Citation: W. Hinterberger, UNTITLED - FOREWORD, Acta medica austriaca, 21(3), 1994, pp. 210000006-210000006
PROLACTIN - A POSSIBLE MEDIATOR OF GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION IN HUMANS
Authors: HINTERBERGERFISCHER M KIER P SPONA J SEBESTA C TIEFENGRABER E HABERTHEUER KH RUCKSER R SCHMID A KALHS P LECHNER K HINTERBERGER W
Citation: M. Hinterbergerfischer et al., PROLACTIN - A POSSIBLE MEDIATOR OF GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION IN HUMANS, Bone marrow transplantation, 14(3), 1994, pp. 403-406
GRAFT-REJECTION AND 2ND BONE-MARROW TRANSPLANTS FOR ACQUIRED APLASTIC-ANEMIA - A REPORT FROM THE APLASTIC-ANEMIA WORKING PARTY OF THE EUROPEAN-BONE-MARROW-TRANSPLANT-GROUP
Authors: MCCANN SR BACIGALUPO A GLUCKMAN E HINTERBERGER W HOWS J LJUNGMAN P MARIN P NISSEN C KERTHOF EV RAGHAVACHAR A SOCIE G FRICKHOFEN N LOCASCIULLI A SCHREZENMEIER H
Citation: Sr. Mccann et al., GRAFT-REJECTION AND 2ND BONE-MARROW TRANSPLANTS FOR ACQUIRED APLASTIC-ANEMIA - A REPORT FROM THE APLASTIC-ANEMIA WORKING PARTY OF THE EUROPEAN-BONE-MARROW-TRANSPLANT-GROUP, Bone marrow transplantation, 13(3), 1994, pp. 233-237
THE IMPORTANCE OF ENUMERATION OF CD 34 PO SITIVE CELLS BEFORE STEM-CELL COLLECTIONS
Authors: KIER P HUBER K RUCKSER R HABERTHEUER KH BAUER K HOCKER P KURZ M TIEFENGRABER E SEBESTA C HINTERBERGER W
Citation: P. Kier et al., THE IMPORTANCE OF ENUMERATION OF CD 34 PO SITIVE CELLS BEFORE STEM-CELL COLLECTIONS, Wiener Klinische Wochenschrift, 106(8), 1994, pp. 238-241
Risultati: 1-25 | 26-31